the present experiments compared the ability of a new potential antipsychotic drug , bmy 14802 ( alpha- ( 4-fluorophenyl ) -4- ( 5-fluoro-2-pyrimidinyl ) -1-piperazine- butanol ) , to alter the electrophysiological activity of midbrain dopamine ( da ) neurons in the rat substantia nigra ( a9 ) and ventral tegmental area ( a10 ) .
C0025462
midbrain
C0038590
substantia nigra